Completed
Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems (YuChooSeR)
Multicenter Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice
- Sponsor
- Translumina GmbH (Industry)
- Enrolment
- 2,722 enrolled
- Conditions
- Coronaropathy
- Interventions
- Yukon Choice PC and Yukon Chrome PC
- Ages
- adults, older adults
- Registry
- NCT03918070
Full record on ClinicalTrials.gov
From the registry
The TRANSLUMINA GmbH YuChooSeR Observatory is a prospective, multicentric post-marketing observatory designed to evaluate large scale safety and reliability of the Yukon Choice PC and the Yukon Chrome PC stents systems use in routine, clinical practice. This based observatory will enroll 3000 patients to 30 sites in France.
Primary outcomes
- The primary endpoint is Target Lesion Failure (TLF) rate at 12 months follow-up
History
Last registry update
Study completion
Primary completion
Registered
Started